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Pilocarpine injection induces epileptic seizures in rodents, an experimental paradigm extensively used to model temporal lobe epilepsy
in humans. It includes conspicuous neuronal death in the forebrain and previous work has demonstrated an involvement of the neu-
rotrophin receptor p75NTR in this process. Following the identification of Galectin-1 (Gal-1) as a downstream effector of p75NTR, we
examinehere the role of this endogenous lectin inpilocarpine-inducedcell death inadultmice.We found thatmost somatostatin-positive
neurons also express Gal-1 and that in mice lacking the corresponding gene Lgals1, pilocarpine-induced neuronal death was essentially
abolished in the forebrain.We also found that the related lectin Galectin-3 (Gal-3) was strongly upregulated by pilocarpine inmicroglial
cells. This upregulation was absent in Lgals1 mutants and our results with Lgals3-null animals show that Gal-3 is not required for
neuronal death in the hippocampus. These findings provide new insights into the roles and regulation of endogenous lectins in the adult
CNS and a surprisingly selective proapoptotic role of Gal-1 for a subpopulation of GABAergic interneurons.
Introduction
Neuronal death is a significant feature of temporal epilepsy in
humans, a frequent condition that can be usefully modeled in
rodents by injecting the muscarinic receptor agonist pilocarpine
(Curia et al., 2008). Like in temporal epilepsy, pilocarpine-
induced seizures cause cell death and decrease the number of
parvalbumin-positive and somatostatin-positive interneurons in
the dentate gyrus of rodents, thus explaining reduced inhibition
in granule cells (Kobayashi and Buckmaster, 2003). With regard
to mechanistic insights, it has been reported that in the hip-
pocampus, the entorhinal, and the piriform cortex, pilocarpine
induces the overexpression of the neurotrophin receptor p75NTR
(Roux et al., 1999), a molecule associated with cell death in the
nervous system, both during development and in a variety of
CNS pathologies in the adult (Dechant and Barde, 2002). Fur-
thermore, cell death was shown to be significantly reduced in
animals lacking p75NTR (Troy et al., 2002) by mechanisms in-
volving the p75NTR interactor neurotrophin receptor-interacting
factor (NRIF) (Volosin et al., 2008). Using neurons generated
from engineered embryonic stem cells (Bibel et al., 2004), we
previously showed that Galectin-1 (Gal-1) is a downstream effec-
tor of p75NTR, which triggers the disintegration of axons and cell
death (Plachta et al., 2007). Gal-1 is a 14 kDa protein belonging to
a multimember lectin family with affinity for -galactoside moi-
eties present in a wide range of cell surface glycoproteins (Bar-
ondes et al., 1994). Its reported role in the nervous system is
complex and includes both positive as well as negative effects on
neurogenesis, cell survival, and axonal elongation (for a recent
review, see Sakaguchi and Okano, 2012). Here we assess the role
of Gal-1 in pilocarpine-induced seizures using mice lacking
Lgals1. We also examine the potential involvement of Galectin-3
(Gal-3) following the realization that pilocarpine also increases
the levels of this lectin in the brain.
Materials andMethods
Pilocarpine-induced status epilepticus and brain sections.All animal exper-
iments were approved by the local veterinarian authorities regulating
animal experimentation in Basel. Three-month-old adult mice of either
sex were injected with methyl scopolamine (1 mg/kg, i.p.) and 30 min
after with pilocarpine hydrochloride (320 mg/kg, i.p.). The mice were
wild-type C57BL/6J, Lgals1/ on a C57BL/6J background, or
Lgals3/ on a C57BL/6J background. Animal behavior was recorded
for the next 2 h (Morrison et al., 1996), and then animals were injected
with diazepam (10mg/kg) to stop the seizures. Controlmice received the
same treatment except that they were injected with saline (0.9% NaCl in
H2O, i.p.) instead of pilocarpine. Animals were injected subcutaneously
with Hartman’s solution (130 mM NaCl, 4 mM KCl, 3 mM CaCl, 28 mM
lactate) during the recovery period. Only mice reaching a crisis level of
5–6 (Morrison et al., 1996) were included in the analysis. Fluoro-JadeB
(FJB)-positive neurons were detected in all wild-type pilocarpine-
injected mice. Twenty-four or 72 h following pilocarpine injection, ani-
mals were deeply anesthetized (ketamine 100 mg/kg, Rompun 0.2%,
i.p.) and transcardially perfused first with ice-cold PBS and followed by
4%PFA in PBS. Brains were removed and postfixed for 1–2 h in the same
fixing solution, cryoprotected with 30% sucrose, embedded in O.C.T.
(Optimal Cutting Temperature compound) and dry-ice frozen. Serial
coronal sections (30 m) were collected using a Leica 3050S cryostat
mounted on laminin-coated microscope slides and stored at70°C.
FJB staining. Consecutive whole-brain coronal sections (30 m;
2.18 to 2.92 mm posterior to bregma) were processed for FJB
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Figure 1. Neuronal death induced by epileptic seizures is blocked in Lgals1mutants. A, FJB staining showing degenerating neurons in different areas of the cerebral cortex and hippocampus, in
wild-type mice injected with saline solution and in wild-type or Lgals1-mutant animals injected with pilocarpine. B, Quantification of the total number of FJB-positive neurons in the cortex and
hippocampus of injected animals, per 30m section. Scale bar, 200m.
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Figure 2. Lack of programmed cell death in Lgals1-mutant mice after pilocarpine-induced seizures. A, TUNEL staining in the parietal cortex, comparing wild-type and Lgals1-mutant mice 24 h
after pilocarpine injection. Scale bar, 100m.B, Quantification of TUNEL-positive cells in theparietal cortex.C, Coimmunostaining forNeuNandactive caspase-3 in theparietal cortex. Scale bar, 100
m. D, Quantification of the NeuN-positive neuron proportion also positive for active caspase-3 staining. E, Colocalization of active caspase-3 and Gal-1 in the CA1 of the hippocampus following
pilocarpine-induced seizures. Scale bar, 50m.
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Figure 3. ThenumberofGal-1-expressingneuronsdecreasesafterepileptic seizures.A,Gal-1 immunoreactivecellsarealmostexclusivelyneurons.Coimmunostaining inthehippocampusandthecerebral cortexwith
antibodiesagainstGal-1andNeuN.B,TheproportionofGal-1-positivecells identifiedasneuronsisplottedasthepercentageofGal-1-immunoreactivecellsalsopositiveforNeuNimmunostaining.C,Thepatternofneuronal
degenerationtriggeredbypilocarpine injectionparallels thepatternofGal-1expression inbasal conditions.D, In theparietal cortex, thenumberofneuronsexpressingGal-1decreases24and72hafterpilocarpine-induced
seizures.E,QuantificationofthetotalnumberofGal-1/NeuNdouble-positiveneuronsinthepiriformcortexandhippocampus,per30msection.F,p75NTRimmunoreactivityinthehippocampusandpiriformcortex24hafter
pilocarpine-inducedseizures.Scalebars:A,C,F,200m;D,100m.n.s.,notstatisticallysignificant.
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staining (Millipore Bioscience Research Reagents) as described previ-
ously (Schmued and Hopkins, 2000). Brain sections were visualized un-
der axioplan2 Zeiss epi-fluorescence microscope and posterior analyzed
using Photoshop software.
TUNEL. TUNEL (terminal deoxynucleotidyl transferase-mediated
UTP nick end labeling) was performed using the In Situ Cell Death
Detection Kit, TMR red (Roche), following provider instructions. Con-
secutive whole-brain coronal sections (30 m; 1.82 to 2.18 mm
posterior to bregma) were labeled and visualized under an axioplan2
Zeiss epi-fluorescence microscope.
Immunohistochemistry. Serial coronal sections were processed for im-
munohistochemistry. The sections were washed in PBS, permeabilized
by incubating in PBS containing 0.2% Triton X-100, and blocked with
10% inactivated horse serum, except for p75NTR staining examined un-
der nonpermeabilizing condition by omitting Triton X-100. The slices
were then incubated overnight at 4°C with primary antibodies. We used
goat anti-Gal-1 at 1:500 (R&D Systems), goat anti-Gal-3 at 1:1000 (R&D
Systems), mouse anti-NeuN at 1:200 (Millipore), rabbit anti-p75NTR at
1:500 (Millipore Bioscience Research Reagents), mouse anti-active anti-
caspase-3 at 1:100 (Millipore), mouse anti-GFAP at 1:1000 (Sigma-
Aldrich), rabbit anti-parvalbumin at 1:200 (Swant), rabbit anti-somatostatin at
Figure 4. Gal-1-positive neurons are also somatostatin-positive. A, Colocalization of Gal-1-
positive and somatostatin-positive neurons (asterisks) in the hippocampus of wild-type mice.
Note that somatostatin neurons are still present in the hippocampus of Lgals1/ mice. B,
Most (arrows), but not all (arrowhead), paravalbumin-positive neurons do not express Gal-1
(asterisks).
Figure 5. Gal-1 expression increases in astrocytes 72 h after epileptic seizures. A, Co-
immunostaining for Gal-1 and GFAP in the piriform cortex. B, Quantification of the num-
ber of Gal-1-positive cells also positive for GFAP in the cerebral cortex and the
hippocampus. Scale bar, 100m.
15594 • J. Neurosci., October 31, 2012 • 32(44):15590–15600 Bischoff, Deogracias et al. • Gal-1 Requirement in Seizure-Induced Cell Death
1:200 (Immunostar), and rat anti-CD11b (Abcam). After washes, sec-
ondary fluorochrome-conjugated antibodies (1:500; Jackson Labora-
tory) were applied for 1 h at room temperature. Sections were mounted
and images collected on either a Zeiss axioplan2 epi-fluorescence micro-
scope or on a Leica SP1 laser scanning confocal microscope and pro-
cessed and analyzed using Photoshop software.
Data analysis.All results presented here correspond to themean of the
quantifications established for each experimental condition (3–6 sec-
tions per animal and 3 or more animals for each time point). The varia-
tion between animals is indicated as SEM and analyzed by unpaired
Student’s t test. A 95% confidence interval was used and values of p 
0.05 were considered as statistically significant. Means were considered
significantly different according to the p value indicated with the follow-
ing symbols: *p 0.05, **p 0.01, and ***p 0.001. Calculations and
statistical analysis were done with Excel and GraphPad Prism 4.0.
Results
Pilocarpine injection in Lgals1-mutant mice
Mice lacking Lgals1, the gene encoding Gal-1, do not show any
overt phenotype (Poirier and Robertson, 1993), and we found no
difference between wild-type and mutant animals in the induc-
ibility or severity of seizures triggered by pilocarpine systemic
injection (data not shown). Neuronal death in the forebrain was
quantified with FJB staining at two different time points follow-
ing pilocarpine injection. Following saline injections in wild-type
Figure 6. Glial reactivity is blocked in Lgals1-mutant mice after pilocarpine injection. A, Astrocyte-specific GFAP immunostaining in the cerebral cortex and hippocampus, comparing wild-type
and Lgals1-mutantmice, 24 and72hafter injection.B,Microglia-specific CD11b immunostaining in the cerebral cortex andhippocampus inwild-type versus Lgals1-mutantmice 24hafter injection.
Scale bar, 200m.
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animals, we found 1.0 1.0 and 1.4 1.8 FJB-positive neurons
after 24 h in the hippocampus and in the parietal and pirifom
cortex, respectively, andnone after 72 h (Fig. 1A,B). Twenty-four
hours following pilocarpine injection, there were 1035 17 and
3228  66 FJB-positive neurons in the hippocampus and the
cortex, respectively. After 72 h, the counts were 510  82 and
2977 127 in the same structures, suggesting thatmany neurons
prone to death following pilocarpine injection had already died
Figure7. p75 NTR is overexpressed in Lgals1mutantmice after pilocarpine injection.A, p75 NTR immunostaining in the parietal cortex and hippocampus, comparingwild-type and Lgals1-mutant
mice, 24 h after injection. Scale bar, 200m. B, p75 NTR is expressed in the Gal-1-positive neurons (asterisks) 24 h after pilocarpine injections in the hippocampus (arrows).
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at early time points (Fig. 1A,B). By contrast, remarkably few
FJB-positive neurons were found in the forebrain of Lgals1 mu-
tants after pilocarpine injection (24  6 and 8  2 FJB-positive
neurons after 24 h; 0 and 1 1 FJB-positive neurons after 72 h in
the hippocampus and the cortex, respectively) (Fig. 1A,B). As the
nature of FJB staining is still somewhat unclear with regard to
what is currently known about the mechanisms of cell death, we
also quantified apoptotic cell death in the cerebral cortex using
the reaction involving TUNEL and active caspase-3 staining (Fig.
2). In wild-type mice, pilocarpine injection triggers apoptotic
death after 24 h (47.6  4.4 TUNEL-positive cells per mm2 vs
1.5  0.5 for saline-injected animals). As with FJB staining, the
number of TUNEL-positive cells detected in Lgals1-mutant mice
injected with pilocarpine was onlymarginally increased (4.4 1)
and not significantly different from saline-injected wild-type animals.
After pilocarpine injection, the proportion of caspase-3-positive
and NeuN-positive neurons was also much lower in Lgals1-
mutant mice compared with wild-type animals (5  1% vs
32.6  1.9%, respectively), and not significantly different from
wild-type control injected with saline (5.5  0.6%). These two
alternative methods confirm the results obtained with FJB stain-
ing and indicate that, in absence of Gal-1, pilocarpine injection
fails to trigger apoptosis of forebrain neurons. Because our pre-
vious work indicated that Gal-1 is upregulated by increased levels
of p75NTR (Plachta et al., 2007), we then wondered whether the
decreased number of Gal-1-expressing neurons following pilo-
carpine injection is the result of their elimination by pro-
grammed cell death. Twenty-four hours after pilocarpine-
induced seizures, we found that caspase-3 was activated in
neurons also expressing Gal-1 (Fig. 2). In control animals, no
caspase-3-positive neurons could be detected that were also Gal-
1-positive. These results suggest that neurons expressing Gal-1,
compared with Gal-1-negative neurons, may be more prone to
degeneration caused by pilocarpine injections.
Gal-1 expression in the forebrain and pilocarpine injection
In wild-type, untreated animals, scattered cells were found to
express Gal-1 mostly in the cerebral cortex and the hippocampus
(Fig. 3A) and costaining with NeuN anti-
bodies revealed that essentially all Gal-1-
positive cells were neurons (Fig. 3B). This
neuron-specific expression of Gal-1
closely matched the pattern of neuronal
degeneration in pilocarpine-injected ani-
mals (Fig. 3C). Remarkably, the number
of neurons labeled with Gal-1 antibodies
was markedly reduced, both in the cere-
bral cortex and in the hippocampus al-
ready 24 h after pilocarpine injection (Fig.
3D,E). This number was not further re-
duced 72 h after injection. In the cerebral
cortex, we counted 256  26 Gal-1-
positive neurons 24 h after the crisis and
291  26 after 72 h versus 762  38 in
saline-injected controls. In the hippocam-
pus, we counted 66 6 (24 h) and 78 10
(72 h) Gal-1-positive neurons in
pilocarpine-treated mice versus 272 23
in the saline-injected animals (Fig. 3E). In
addition, we observed that many more
cells expressed p75NTR after pilocarpine
injection compared with control animals
(Fig. 3F), in line with previous findings
(Roux et al., 1999). As pilocarpine injection in rats has been
shown to cause the death of interneurons in the dentate gyrus
(Kobayashi and Buckmaster, 2003), we examined the possibility
that Gal-1 may colocalize with somatostatin and parvalbumin,
two well known markers of subpopulations of interneurons. We
found that, in control animals injected with saline, all Gal-1-
positive neurons also expressed somatostatin. We found that,
conversely, of the total number of somatostatin neurons (N 
487), 95.27 3.8% also expressed Gal-1, while of the total num-
ber of parvalbumin cells (N  628), only 15.6  3.4% coex-
pressed Gal-1. Following pilocarpine injections, both
somatostatin-positive and Gal-1-positive neurons were essen-
tially eliminated after 24 h (saline, N 42 neurons; pilocarpine,
N  5 neurons; 6 consecutive sections) (Fig. 4A). By contrast,
parvalbumin-positive neurons could still be readily detected (sa-
line, N 115 neurons; pilocarpine, N 110 neurons; 6 consec-
utive sections) (Fig. 4B).
While very few Gal-1-positive cells are also positive for the
astrocytic marker GFAP under control conditions, this propor-
tion increased markedly with time following pilocarpine injec-
tion and seizures (Fig. 5A,B). In control animals, only 2.2 and
1.1% Gal-1-positive cells also expressed GFAP in the hippocam-
pus and the cortex, respectively, while 18.3 and 6.3% were
double-labeled 24 h after pilocarpine treatment, and as many
78.8 and 74.2% at 72 h. These results are in line with a previous
report using injection of kainic acid to trigger neuronal degener-
ation (Kajitani et al., 2009).
Glial cells reactivity and p75NTR expression in wild-type and
Lgals1-mutant brains after pilocarpine injection
Neuronal degeneration is well known to be accompanied by a
strong glial reaction (Barres, 2008) and, as expected, we observed
a large increase in the number of GFAP-positive astrocytes and of
CD11b-positive microglial cells in the forebrain of wild-type an-
imals treated with pilocarpine (Fig. 6A,B). By contrast, no signs
of glial reactivity were observed at 24 or 72 h following pilo-
carpine injection in Lgals1 animals (Fig. 6A,B). Despite the ab-
sence of neuronal death and glial reactivity, we found that
Figure 8. Gal-3 is expressed in microglial cells after epileptic seizures, but not in Lgals1-mutant mice. Coimmunostaining for
Gal-3 and CD11b in the parietal cortex. Scale bar, 100m.
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p75NTR was still overexpressed in these Lgals1-mutant animals
after pilocarpine injection (Fig. 7A). Conversely, all cells express-
ing Gal-1 24 h after pilocarpine injections were also positive for
p75NTR, both in the dentate gyrus and inCA2 (Fig. 7B). Together,
these results indicate that p75NTR overexpression per se is not
sufficient to cause cell death following pilocarpine injection.
Expression and role of Galectin-3 in the forebrain
Gal-3 is structurally related to Gal-1 and is involved in T-cell
apoptosis (Hsu et al., 2009). Also, its role has been recently inves-
tigated in the context of cerebral ischemia (Doverhag et al., 2010;
Lalancette-He´bert et al., 2012). We found Gal-3 to be strongly
upregulated as early as 24 h after pilocarpine-induced seizures
(Fig. 8), with an expression pattern closely matching neuronal
degeneration revealed by FJB staining in the hippocampus and
cortex (Fig. 9). Using the microglial marker CD11b, Gal-3 was
found to be exclusively expressed by microglial cells, and not by
astrocytes or neurons (Fig. 8). These results are in line with those
reported in a recent study indicating that microglial cells express
Gal-3 in a mouse model of cerebral ischemia (Lalancette-He´bert
et al., 2012). In animals lacking Gal-1, we found that Gal-3 was
not upregulated in these or any other cells in the forebrain (Fig.
8), indicating that Gal-1 is required both for the induction of
neuronal death and the upregulation of Gal-3 by microglial cells
following pilocarpine injection. We next directly examined the
possibility that Gal-3 may also be required, like Gal-1, for cell
death following pilocarpine-induced seizures.Usingmice lacking
Lgals3, we found a small, but significant reduction of cell death in
the cerebral cortex, but not in the hippocampus (Fig. 9). It thus
seems that despite upregulation in microglial cells following pi-
locarpine injection, Gal-3 plays a marginal role compared with
Gal-1 as a cell death effector. Unlike in the model of cerebral
ischemia (Lalancette-He´bert et al., 2012), our results do not sug-
gest a protective role for Gal-3 with regard to the prevention of
cell death.
Discussion
Our results reveal that Gal-1 plays an essential role in the neuro-
degeneration process triggered in the forebrain following
systemic pilocarpine administration. Gal-1 is expressed predom-
inantly by somatostatin-positive interneurons and is required for
their death during seizures. By contrast, cell death is only mar-
ginally reduced in animals lacking Gal-3, and only in the cerebral
cortex, not in the hippocampus, despite a strongGal-3 expression
throughout the forebrain by microglial cells following pilo-
carpine injection.
Galectin-1 and cell death
Gal-1 is known to induce the cell death in the immune systemand
to regulate T-cell homoeostasis during the development in the
thymus as well as after their activation in the periphery (Perillo et
al., 1995; Rabinovich et al., 2007). By contrast, still very little is
known about the role of galectins in the mouse nervous system,
which seems to develop without gross alterations in the absence
of both Gal-1 and Gal-3. Also, mice lacking both genes are fertile
and do not display any overt phenotype. Upon closer examina-
tion, animals constitutively lacking Gal-1 show discrete altera-
tions in the projections of olfactory axons (Puche et al., 1996) and
in subsets of sensory afferents (McGraw et al., 2005). Previous
reports also noted that Gal-1 expression by GFAP-positive cells
promotes basal and kainate-induced proliferation of neuronal
progenitors in the hippocampus (Sakaguchi et al., 2007; Sakagu-
chi and Okano, 2012) and recovery after stroke (Ishibashi et al.,
2007). By contrast, our previous results indicated that Gal-1 pro-
motes axonal degeneration caused by p75NTR overexpression
and that it participates in excitotoxic cell death following ibotenic
acid injections in rats, a treatment that also includes the upregu-
lation of p75NTR (Plachta et al., 2007). It is not easy at this point to
reconcile these somewhat disparate findings. They may in part
result from the fact that Gal-1 interacts with a number of mem-
brane glycoproteins as well as with molecules of the extracellular
matrix (Camby et al., 2006). Also, Gal-1 is only expressed in the
forebrain by a small population of neurons largely corresponding
to somatostatin-positive interneurons, a subpopulation that is
Figure 9. Pilocarpine-induced seizures trigger neuronal degeneration in Lgals3-mutant
mice. A, Coimmunostaining for Gal-3 and CD11b in the parietal cortex 72 h after pilocarpine
injection. B, Quantification of the total FJB-positive neurons in the cerebral cortex and hip-
pocampus of injected animals. Scale bar, 100m. n.s., not statistically significant.
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essentially eliminated during the course of seizures triggered by
pilocarpine injections. This is functionally interesting as the loss
of inhibitory neurons has been previously suggested to be part of
the physiopathology of seizure in the rodent dentate gyrus (Ko-
bayashi and Buckmaster, 2003).
The mechanisms by which Gal-1 kills neurons expressing this
lectin remain unclear and, given the number of molecules ex-
pressing -galactoside moieties, a deeper understanding of these
mechanisms may not be straightforward. In fact, it is not even
clear how Gal-1 reaches the cell surface as it does not have the
characteristics of a secretory protein (Vasta, 2012). While it is
conceivable that Gal-1 may act intracellularly, our previous in
vitro observations indicate that it is accessible to extracellular
reagents as the killing activity of Gal-1 can be prevented by the
addition of antibodies or of excess galactose to cultured cells
(Plachta et al., 2007). Our results also indicate that Gal-1 expres-
sion is not limited to neurons. Following pilocarpine injection,
most astrocytes become strongly immunoreactive for Gal-1,
though this is a comparatively late process, reaching completion
72 h after seizure initiation, significantly later than the onset of
neuronal death. Also, this late increase does not cause the death of
reactive astrocytes. In fact, the number of GFAP-positive cells
increases markedly at 72 h (Figs. 5, 6A) and, as observed inmany
experimental models of brain damage (Barres, 2008), this astro-
cytic reaction may be a consequence, rather than a cause, of neu-
ronal death and it is not observed in Lgals1 mutants after
pilocarpine injection (Fig. 6).
Pilocarpine-induced seizure, Gal-3, and p75NTR
Gal-3 is closely related toGal-1 and has also been shown to trigger
the death of activated T-cells, albeit by the activation of cell sur-
face receptors that differ from those used byGal-1 (Stillman et al.,
2006).We found that while there is very little Gal-3 expression in
the CNS under control conditions, microglial cells become
strongly positive for Gal-3 after pilocarpine. However, this is a
process that is strictly Gal-1 dependent (Fig. 8). The conclusion
that Gal-3 is expressed by microglial cells after pilocarpine injec-
tion is in agreementwith results recently published by Lalancette-
He´bert and colleagues (2012). Following middle cerebral artery
occlusion, Gal-3 was found to be markedly upregulated in Iba-1-
positive cells used as microglia markers. In Lgals3 mutants, this
lectin was also shown to be required for microglia activation and
proliferation after ischemia. However, in this paradigm, the lack
of Gal-3 also correlated with increased cell death, which was in-
creased by2-fold after temporary artery occlusion (Lalancette-
He´bert et al., 2012). This is very different from what we observed
in the pilocarpine-induced seizure paradigm: there is a modest
decrease of cell death in the cortex of the Lgals3 mutant with
no change in the hippocampus (Fig. 9). Apparently then, the
role of Gal-3 in CNS pathologies also depends on the type of
lesion inflicted with ischemia likely to generate much higher
levels of cell death in the brain then localized seizure episodes
of short duration. While the functional role of Gal-3 expressed
by microglial cells after seizures remains unclear, it could be
related to the phagocytosis of dead neurons or cellular debris
resulting from neuronal death. This hypothesis is also sup-
ported by the pattern of Gal-3 expression and of neuronal
degeneration (Fig. 9), and the observation that some Gal-3-
positive microglial cells were seen to engulf dying neurons
(data not shown). We note that in the lesioned peripheral
nervous system, Gal-3, then known under the name of the
MAC-2 antigen, was suggested early on to facilitate the re-
moval of debris of injured axons and thus to promote axonal
regeneration (Rotshenker, 2011).
In our experimental seizure paradigm, Gal-1 appears to be a
more accurate predictor of cell death than p75NTR as many more
cells express this pan-neurotrophin receptor and survive pilo-
carpine injection than is the case for neurons expressing both
p75NTR and Gal-1. Also, pilocarpine-induced neuronal death is
essentially abolished in the Lgals1 mutant while a proportion of
neurons still die inmutants lacking p75NTR (Troy et al., 2002). In
Lgals1mutants injected with pilocarpine, p75NTR overexpression
does not seem to be markedly reduced, suggesting that Gal-1 is
not required for the expression of this receptor and that overex-
pression of p75NTR alone is not a faithful predictor of neuronal
death.
In conclusion, our results demonstrate that Gal-1 plays a key
role in the death of interneurons in the pilocarpine seizure-
inducing model, bringing new insights into the understanding of
neurodegeneration caused by excessive neuronal activity. Inter-
fering with the activity of Gal-1 in temporal epilepsy may then
represent a new possibility to reduce the loss of neurons in hu-
mans. This is of special interest given the difficulties encountered
using glutamate receptor antagonist (for review, see Wang and
Qin, 2010).
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